Most Read Articles
Elaine Soliven, 5 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Transcutaneous neuromodulation at ST36 trumps tibial nerve stimulation in treating constipation

25 Jun 2020
Acupuncture is said to realign the flow of “qi” that was disrupted in the body.

Transcutaneous neuromodulation (TN) at acupoint Zusanli (ST36) appears to be more potent than TN at posterior tibial nerve (PTN) in the treatment of constipation and its related symptoms and rectal sensation, a study has shown.

Nine male and nine female functional constipation patients participated in this crossover study with a 2-week TN at ST36 and a 2-week TN at PTN. Participants completed a bowel movement diary, as well as the questionnaires of Patient Assessment of Constipation Symptom (PAC-SYM) and Constipation Quality of Life (PAC-QoL). The investigators also performed anorectal manometry and spectral analysis of heart rate variability for assessing the autonomic function.

Both TN at ST36 and at PTN improved constipation-related symptoms (PAC-SYM scores on pre-TN vs post-TN: 1.4±0.1 vs 0.6±0.1 for ST36; 1.4±0.1 vs 0.9±0.1 for PTN; pboth≤0.001). TN at ST36 increased the number of weekly spontaneous bowel movements (pre-TN vs post-TN: 0.9±0.2 vs 3.5±0.7; p<0.001) and decreased the total PAC-QoL score, but TN at PTN did not. Moreover, TN at ST36 was more effective than TN at PTN in improving PAC-SYM score (decrement: 0.8±0.1 vs 0.5±0.1; p<0.05).

TN at ST36, but not at PTN, reduced sensation thresholds, including rectal distention for urge (pre-TN vs post-TN: 134.1±14.3 vs 85.6±6.5 mL; p<0.01) and maximum tolerance (p<0.05). Finally, both TN at ST36 and at PTN resulted in significant increase in vagal activity and decrease in sympathetic activity (p<0.05).

“Combined TN at acupoint ST36 and TN at PTN has been reported effective in treating functional constipation,” the investigators noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 5 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.